Sign In / Join

favorite Donate

close

person Sign In / Create Account

HealthTree News

HealthTree News is a place to learn all about your disease in easy-to-understand language. The site features news articles, patient stories, basics articles, and clinical trial updates with new content every week.

Headlines All Categories Treatment Advances Navigating Your Health Core Education Patient Stories HealthTree Research Conferences Clinical Trials HealthTree Programs HealthTree Press

How Substance Use Impacts Cancer Care: Breaking the Stigma to Improve Patient Outcomes

May. 07, 2025

How Substance Use Impacts Cancer Care: Breaking the Stigma to Improve Patient Outcomes

Adding Ibrutinib to Enhance Liso-cel’s Effect Against CLL

May. 07, 2025

Adding Ibrutinib to Enhance Liso-cel’s Effect Against CLL

$Brexucabtagene Autoleucel for Relapsed/Refractory ALL$

May. 06, 2025

Brexucabtagene Autoleucel for Relapsed/Refractory ALL

Combining New and Traditional Therapies for AML and MDS Treatment

May. 06, 2025

Combining New and Traditional Therapies for AML and MDS Treatment

Understanding and Managing Brain-Related Side Effects of Blood Cancer Treatments

May. 05, 2025

Understanding and Managing Brain-Related Side Effects of Blood Cancer Treatments

Senate Committee Champions Biomedical Research Funding that Advances Cancer Care

May. 02, 2025

Senate Committee Champions Biomedical Research Funding that Advances Cancer Care

New Treatment for Low Platelet Levels in CMML

May. 01, 2025

New Treatment for Low Platelet Levels in CMML

Moving Pirtobrutinib to a First-Time Treatment for CLL/SLL?

Apr. 30, 2025

Moving Pirtobrutinib to a First-Time Treatment for CLL/SLL?

How Are Steroids Used in Blood Cancer Treatment?

Apr. 29, 2025

How Are Steroids Used in Blood Cancer Treatment?

Menin Inhibitors: A New Treatment Option for Acute Leukemia Patients

Apr. 29, 2025

Menin Inhibitors: A New Treatment Option for Acute Leukemia Patients

Can CLL Treatment Time Be Shortened with MRD Testing?

Apr. 28, 2025

Can CLL Treatment Time Be Shortened with MRD Testing?

CML vs CLL: Similarities and Differences

Apr. 28, 2025

CML vs CLL: Similarities and Differences

Recent Articles

Vibecotamab: A Potential Treatment Option for Myeloid Blood Cancers image

Vibecotamab: A Potential Treatment Option for Myeloid Blood Cancers

April 25, 2025

Learn how vibecotamab targets CD123 to treat myelodysplastic syndrome, chronic myelomonocytic leukemia, and acute myeloid leukemia.

Investigating a New Oral Combination for Relapsed/Refractory CLL and Richter Transformation image

Investigating a New Oral Combination for Relapsed/Refractory CLL and Richter Transformation

April 25, 2025

Learn about an all-oral treatment with venetoclax and duvelisib for relapsed or refractory CLL and RS, including effectiveness and side effects.

Survival Outcomes In Young People with Relapsed T-Cell Acute Lymphoblastic Leukemia (T-ALL) and T-Cell Lymphoblastic Lymphoma (T-LL) image

Survival Outcomes In Young People with Relapsed T-Cell Acute Lymphoblastic Leukemia (T-ALL) and T-Cell Lymphoblastic Lymphoma (T-LL)

April 25, 2025

Learn about the latest research on survival rates, remission, and stem cell transplants in young patients with relapsed or refractory T-ALL and T-LL

Treatment Advances

Brexucabtagene Autoleucel for Relapsed/Refractory ALL image

Brexucabtagene Autoleucel for Relapsed/Refractory ALL

Combining New and Traditional Therapies for AML and MDS Treatment image

Combining New and Traditional Therapies for AML and MDS Treatment

New Treatment for Low Platelet Levels in CMML image

New Treatment for Low Platelet Levels in CMML

Menin Inhibitors: A New Treatment Option for Acute Leukemia Patients image

Menin Inhibitors: A New Treatment Option for Acute Leukemia Patients

Vibecotamab: A Potential Treatment Option for Myeloid Blood Cancers image

Vibecotamab: A Potential Treatment Option for Myeloid Blood Cancers

Investigating a New Oral Combination for Relapsed/Refractory CLL and Richter Transformation image

Investigating a New Oral Combination for Relapsed/Refractory CLL and Richter Transformation

Load More

Core Education

How Are Steroids Used in Blood Cancer Treatment? image

How Are Steroids Used in Blood Cancer Treatment?

CML vs CLL: Similarities and Differences image

CML vs CLL: Similarities and Differences

How TET2 Plays A Pivotal Role In CMML image

How TET2 Plays A Pivotal Role In CMML

What Are Hypomethylating Agents And How Do They Treat CMML? image

What Are Hypomethylating Agents And How Do They Treat CMML?

Understanding the Timing of Treatment in Acute Myeloid Leukemia (AML) image

Understanding the Timing of Treatment in Acute Myeloid Leukemia (AML)

What Are Cytokine Receptors and How Do They Affect Acute Lymphoblastic Leukemia (ALL)? image

What Are Cytokine Receptors and How Do They Affect Acute Lymphoblastic Leukemia (ALL)?

Load More

Trending Articles

How Blood Cancer Patients Are Finding Purpose, Growth, and Meaning After Diagnosis

Survival Outcomes In Young People with Relapsed T-Cell Acute Lymphoblastic Leukemia (T-ALL) and T-Cell Lymphoblastic Lymphoma (T-LL)

CML vs CLL: Similarities and Differences

Menin Inhibitors: A New Treatment Option for Acute Leukemia Patients

Patient Stories

articles for Patient Stories

Former NHL Player Kelly Chase Shares an Update on His AML Treatment James' Journey with AML: A Story of Resilience and Acceptance Diane’s CLL Story - Empowered Through Education and Wellness Methods

HealthTree Research

articles for HealthTree Research

How Blood Cancer Patients Are Finding Purpose, Growth, and Meaning After Diagnosis Share HealthTree Cure Hub to Accelerate CLL Research Participate in CLL Research: Health History Surveys

Conferences

articles for Conferences

Can CLL Treatment Time Be Shortened with MRD Testing? Survival Outcomes In Young People with Relapsed T-Cell Acute Lymphoblastic Leukemia (T-ALL) and T-Cell Lymphoblastic Lymphoma (T-LL) Updates on NeoVax, a Vaccine for CLL

Clinical Trials

articles for Clinical Trials

Adding Ibrutinib to Enhance Liso-cel’s Effect Against CLL Moving Pirtobrutinib to a First-Time Treatment for CLL/SLL? Gemtuzumab Ozogamicin for Pediatric AML

HealthTree Press

articles for HealthTree Press

HealthTree Foundation CEO Jenny Ahlstrom Honored as 2025 Remarkable Women Honoree by ABC4 Utah Jenny Ahlstrom Recognized Among Nation's Top Female Founders by Inc. HealthTree Foundation Launches New Mobile App to Empower Blood Cancer Patients

HealthTree Programs

articles for HealthTree Programs

AML Awareness Day: New Expert Podcast Series to Understand AML Make an Impact with the HealthTree Challenge: Hike and Wellness Event! An Opportunity to Take Action: Regional Cure Teams

All HealthTree resources available anywhere, anytime

Download our App

Download iOS App

Download Android App

iphone app mockup

Download our App

Download iOS App

Download Android App

Charity Navigator

HealthTree Foundation is a qualified 501(c)(3) tax-exempt organization.

Copyright © 2025 HealthTree Foundation. All rights reserved.

Tax ID 45-5354811